comparemela.com
Home
Live Updates
PharmaVentures advises Lausanne Hospital (CHUV) and EPFL on their collaboration and founding of Aerium Therapeutics to develop their highly potent SARS-CoV-2 antibodies : comparemela.com
PharmaVentures advises Lausanne Hospital (CHUV) and EPFL on their collaboration and founding of Aerium Therapeutics to develop their highly potent SARS-CoV-2 antibodies
LONDON, March 24, 2022 /PRNewswire/ -- PharmaVentures is pleased to announce that it acted as transaction advisor to Lausanne University Hospital (CHUV) and EPFL in Switzerland on their commercial
Related Keywords
United States ,
United Kingdom ,
Lake Geneva ,
Switzerland General ,
Switzerland ,
Boston ,
Massachusetts ,
Geneva ,
Genè ,
Zurich ,
Züsz ,
Bern ,
London ,
City Of ,
Swiss ,
Fintan Walton ,
Giuseppe Pantaleo ,
Prnewswire Pharmaventures ,
Alisa Holloway ,
Didier Trono ,
Swiss Federal Institute Of Technology ,
Pharmaventures Ltd ,
Pharmaventures Capital Ltd ,
Financial Conduct Authority ,
Medicine Of The University Lausanne ,
Lausanne University Hospital ,
Allergy Division ,
Aerium Therapeutics ,
Omega Funds ,
Ventures Capital Ltd ,
University Hospital ,
Swiss Federal Institute ,
Pharmaventures ,
Dvises ,
Ausanne ,
Hospital ,
Whuv ,
Pfl ,
Collaboration ,
Founding ,
Cerium ,
Herapeutics ,
Evelop ,
Ighly ,
Kpotent ,
Cars ,
Antibodies ,
comparemela.com © 2020. All Rights Reserved.